Darbepoetin Alfa
Links shared publicly online about this topic
TREAT: Darbepoetin alfa fails in anemic diabetics with CKD
theheart.org — “No differences were seen between groups, except in strokes, which were twice as high in the active-treatment group. Anticipated improvements in fatigue scores were modest and not clinically meaningful, investigators say.” View full resource at theheart.org
Most Recently Shared on October 31, 2009 at 1:04 am By:
heartwire: No TREAT: Darbepoetin alfa fails to reduce CV or renal events in anemic diabetics with CKD http://bit.ly/2vsyPY
Darbepoetin alfa is unsafe as well? | All Kidney News
allkidney.com — “Darbepoetin alfa is a an erythropoesis stimulating agent marketed under the name Aranesp by AMGEN. It is used for the treatment of anemia ( a lower than normal” View full resource at allkidney.com
Most Recently Shared on November 2, 2009 at 11:37 pm By:
Roger Smith Doctor, Internist, Nephrologist, and Physician
Darbepoetin alfa is unsafe as well? http://bit.ly/4rZUdN via @AddToAny
Dr Reddy's launches first generic darbepoetin alfa
news-medical.net — “Dr. Reddy's Laboratories Ltd. announced today the launch of Cresp® - the first generic darbepoetin alfa in the world, and the only darbepoetin alfa in India. Cresp® has been approved in India for the treatment of anemia due to chronic kidney disease and anemia due to chemotherapy.” View full resource at news-medical.net
Most Recently Shared on August 9, 2010 at 2:32 pm By:
Dr Reddy’s launches first generic darbepoetin alfa: Dr. Reddy's Laboratories Ltd. announced today the launch of Cr... http://bit.ly/c25KlD
Kidney Patients Not On Dialysis, FDA Advisers Recommend Continuation Of Aranesp (Darbepoetin Alfa)
medicalnewstoday.com — “An FDA Advisory Committee has recommended the continued use of Aranesp (Darbepoetin alfa), a synthetic form of erythropoietin used to treat anemia in patients with mild to moderate chronic (long-t” View full resource at medicalnewstoday.com
Most Recently Shared on October 19, 2010 at 1:08 am By:
Kidney Patients Not On Dialysis, FDA Advisers Recommend Continuation Of Aranesp (Darbepoetin Alfa) An FDA Advisory Comm.. http://dld.bz/2kd8
TREAT: Darbepoetin alfa fails in anemic diabetics with CKD | theheart.org
theheart.org — “Articles written by renowned physicians on recent developments and advancements in brain, kidney and peripheral medicine. Sign up for regular industry updates.” View full resource at theheart.org
Most Recently Shared on October 18, 2010 at 3:24 pm By:
For full coverage of the TREAT trial, presented in October 2009 by Dr Marc Pfeffer, see heartwire's coverage at http://bit.ly/4oSz6k.
FDA Advisors Go Easy on Aranesp (darbepoetin alfa) « CardioBrief
cardiobrief.org — “FDA Advisors Go Easy on Aranesp (darbepoetin alfa) « CardioBrief” View full resource at cardiobrief.org
Most Recently Shared on October 18, 2010 at 10:59 pm By:
RenalFellowNetwork Health Site and Nephrology
RT @cardiobrief: FDA Advisors Go Easy on Aranesp (darbepoetin alfa): http://wp.me/ppMHd-1LU #fb
Risks outweighed benefits of darbepoetin alfa in patients with type 2 diabetes, CKD, anemia | Resource Center: Type 2 Diabetes
endocrinetoday.com — “Renal Week 2009Darbepoetin alfa did not decrease the risk for death, cardiovascular or renal events in patients with type 2 diabetes, chronic kidne” View full resource at endocrinetoday.com
Most Recently Shared on November 3, 2009 at 3:45 pm By:
#ASN Risks outweighed benefits of darbepoetin alfa in patients with type 2 #diabetes, chronic kidney disease, anemia http://ow.ly/yVIu
Darbepoetin Alfa Impact on Health Status in Diabetes Patients with Kidney Disease - A Randomized Trial
instapaper.com — “Darbepoetin Alfa Impact on Health Status in Diabetes Patients with Kidney Disease - A Randomized Trial” View full resource at instapaper.com
Most Recently Shared on April 14, 2011 at 8:54 pm By:
Yvo Sijpkens MD Physician, Doctor, Internist, and Nephrologist
Darbepoetin alfa confers a small improvement in fatigue and overall quality of life in patients with #diabetes and CKD: http://t.co/T5A0AKv
Dosing Intervals of Darbepoetin Alfa May Be Extended in Pre-Dialysis Patients - Renal and Urology News
renalandurologynews.com — “LAS VEGAS--"Darbepoetin alfa dosing intervals in pre-dialysis patients with chronic kidney disease (CKD) may be extended beyond the approved one- or two-week frequency, researchers reported at the National Kidney Foundation's Spring Clinical Meetings.” View full resource at renalandurologynews.com
Most Recently Shared on April 28, 2011 at 12:22 pm By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
Dosing Intervals of Darbepoetin Alfa May Be Extended in Pre-Dialysis Patients: LAS VEGAS—Darbepoetin alfa dosing... http://bit.ly/m5JVBs
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease | Nephrology Now
nephrologynow.com — “TREAT: RCT of diabetic CKD patients with anemia, comparing darbepoietin alfa at Hb 110 g/dL vs 90 g/dL. Primary endpoint not reduced and stroke rates increased.” View full resource at nephrologynow.com
Most Recently Shared on November 3, 2009 at 4:52 pm By:
John Hsieh Physician, Doctor, Internist, and Nephrologist
RT @nephrologynow Due to the potential implications of the TREAT study, mailout sent in advance of the full issue http://bit.ly/TREAT
Dr Reddy's launches darbepoetin alfa in India under the brand name 'Cresp' - FiercePharma
fiercepharma.com — “Dr Reddy's launches darbepoetin alfa in India under the brand name ‘Cresp®' - World's first generic darbepoetin alfa and the only one in India August 09, 2010, Hyderabad: Dr. Reddy's... Read more...” View full resource at fiercepharma.com
Most Recently Shared on August 9, 2010 at 12:36 pm By:
Dr Reddy's launches darbepoetin alfa in India under the brand name Cresp. http://bit.ly/c2eHQk
Darbepoetin before FDA panel | theheart.org
theheart.org — “Articles written by renowned physicians on recent developments and advancements in brain, kidney and peripheral medicine. Sign up for regular industry updates.” View full resource at theheart.org
Most Recently Shared on October 19, 2010 at 6:38 pm By:
FDA advisory panel supports continued use of darbepoetin: No label changes proposed: The advisory committee voted ... http://bit.ly/cl2Z7N
FDA panel to review darbepoetin | theheart.org
theheart.org — “Articles written by renowned physicians on recent developments and advancements in brain, kidney and peripheral medicine. Sign up for regular industry updates.” View full resource at theheart.org
Most Recently Shared on October 14, 2010 at 7:42 pm By:
Doubting darbepoetin: FDA documents spell rough ride at Monday advisory panel: An early safety review posted onlin... http://bit.ly/bJRaRx
Vitamin D Repletion May Reduce Darbepoetin Requirements - Renal and Urology News
renalandurologynews.com — “LAS VEGAS--"Vitamin D repletion in patients with end-stage renal disease maintains hemoglobin (Hb) levels and results in decreased requirement of darbepoetin alfa, according to data presented at the National Kidney Foundation's Spring Clinical Meetings.” View full resource at renalandurologynews.com
Most Recently Shared on April 28, 2011 at 4:42 pm By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
Vitamin D Repletion May Reduce Darbepoetin Requirements: LAS VEGAS—Vitamin D repletion in patients with end-stag... http://bit.ly/leTZor
Cardiology Medical News about Heart Failure
mdlinx.com — “Treatment of Anemia With Darbepoetin Alfa in Heart Failure” View full resource at mdlinx.com
Most Recently Shared on February 18, 2010 at 10:27 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cardio: Treatment of Anemia With Darbepoetin Alfa in Heart Failure: Congestive Heart Failure http://bit.ly/aqrvl6
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Roger Smith
Dr. Roger Smith is a nephrologist working in the pblic and private sector health care system of Jamaica.
-
News-Medical.Net
Medical News from Around the World
Advertisement
